Evolus, Inc.
EOLSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for EOLS. That does not mean none is planned.
Get an email about EOLS's next catalysts
Track Evolus (EOLS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Botulinum toxin, Type A
Glabellar Frown Lines
PrabotulinumtoxinA-Xvfs
Glabellar Frown Lines
Botulinum purified neurotoxin, Type A
Glabellar Frown Lines
DWP-450 (Botulinum purified neurotoxin, Type A)
Glabellar Frown Lines
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Botulinum toxin, Type A | Phase 3 | Glabellar Frown Lines | - | - |
PrabotulinumtoxinA-Xvfs | Phase 2 | Glabellar Frown Lines | - | - |
Botulinum purified neurotoxin, Type A | Phase 2 | Glabellar Frown Lines | - | - |
DWP-450 (Botulinum purified neurotoxin, Type A) | Phase 2 | Glabellar Frown Lines | - | - |
Frequently asked questions
What is in Evolus, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Evolus, Inc.'s (EOLS) pipeline across Phase 3, Phase 2. Its lead program is Botulinum toxin, Type A (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Evolus, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Evolus, Inc. (EOLS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EOLS biotech catalysts?→
Add EOLS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Evolus, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.